Because no global Cartiva settlement program currently exists, any projected settlement values are estimates based on the allegations in the litigation, the severity of reported injuries, and compensation trends in comparable medical device cases.
Cartiva lawsuits allege that patients suffered complications ranging from chronic pain and mobility limitations to revision surgeries, implant removal, and permanent impairment after receiving the device.
As a result, potential compensation may vary significantly depending on the extent of a claimant’s injuries, the number of corrective procedures required, and the impact on daily life and employment.
Settlement values in Cartiva implant recall lawsuits will likely take into account factors such as medical bills, future treatment costs, lost wages, pain and suffering, and permanent loss of function.
Based on currently available information, projected Cartiva lawsuit settlement amounts may range from approximately $25,000 to $300,000 or more in the most severe cases.
Tier 1 Cartiva Settlement Projections: $150,000 to $300,000+
The highest projected settlement values are generally associated with injured patients who experienced serious Cartiva implant problems that required multiple surgeries or resulted in permanent impairment.
Many of these claims involve severe pain that persisted long after the original procedure and substantially affected the person’s ability to walk, work, exercise, or perform daily activities.
Plaintiffs in this category often allege that the failed implant caused progressive joint damage that ultimately required fusion surgery or other extensive corrective treatment.
Cases that may fall within this category include:
- Big toe fusion surgery following Cartiva implant failure
- Multiple revision surgeries or surgical procedures
- Significant bone loss or joint destruction
- Chronic severe pain lasting months or years
- Permanent loss of motion in the big toe joint
- Nerve injuries resulting in numbness, tingling, or loss of sensation
- Implant subsidence, displacement, or migration requiring corrective surgery
- Complications identified in recall materials, including pain, nerve damage, fragmentation, and device failure
- Long-term mobility limitations affecting employment or daily activities
- Permanent impairment documented by treating physicians
Projected settlement values for tier 1 claims may range from approximately $150,000 to $300,000 or more, depending on the extent of the injuries, medical treatment, economic losses, and long-term prognosis.
Cases involving permanent disability, substantial lost earnings, or exceptionally severe medical complications could exceed these projections.
Tier 2 Cartiva Settlement Projections: $50,000 to $150,000
This category generally includes claimants who underwent additional treatment after their Cartiva big toe implant failed but did not suffer the most severe long-term outcomes.
Many cases involve corrective foot and ankle surgery, documented mobility limitations, and ongoing symptoms that persisted after the original procedure.
Medical records in these claims often show that the implant sinks into surrounding bone, develops instability within the joint, or otherwise fails to function as intended as a synthetic cartilage device.
Cases that may fall within this category include:
- Revision surgery following Cartiva implant failure
- Implant removal without conversion to fusion surgery
- Persistent pain lasting months or years after implantation
- Implant subsidence where the implant sinks into surrounding bone
- Implant displacement or loosening within the joint
- Development of bone spurs following implantation
- Reduced range of motion in the big toe joint
- Chronic swelling, stiffness, or inflammation
- Difficulty walking, exercising, or performing routine activities
- Ongoing medical treatment, physical therapy, or pain management
Projected settlement values for tier 2 claims may range from approximately $50,000 to $150,000, depending on the extent of the injuries, the cost of treatment, and the duration of symptoms.
Cases involving documented revision procedures, substantial medical expenses, or long-term functional limitations may fall toward the upper end of this projected range.
Tier 3 Cartiva Settlement Projections: $25,000 to $50,000
This category generally includes claimants who experienced complications after receiving a Cartiva SCI but did not require major revision procedures or fusion surgery.
Many of these cases involve ongoing pain, reduced function, and continued medical treatment following implantation.
When a Cartiva implant fails, symptoms can range from intermittent discomfort and stiffness to chronic irritation that affects walking and other daily activities.
Cases that may fall within this category include:
- Persistent but manageable ongoing pain
- Stiffness or reduced range of motion in the big toe joint
- Swelling or inflammation following implantation
- Difficulty with prolonged walking, standing, or exercise
- Conservative treatment with medications or physical therapy
- Medical imaging showing implant-related issues without revision surgery
- Recurring symptoms requiring follow-up care and physician monitoring
- Limitations on recreational activities or hobbies
- Mild to moderate mobility impairment
- Documented implant failure without surgical correction
Projected settlement values for Tier 3 claims may range from approximately $25,000 to $50,000, depending on the duration of symptoms, medical documentation, and the impact the injury has had on the claimant’s daily life.
Cases involving well-documented complications, substantial treatment costs, or worsening symptoms may fall toward the higher end of this projected range.
